A Study to Evaluate the Safety and Feasibility of Exablate Model 4000 Type-2 to temporarily mediate Blood-Brain Barrier Disruption (BBBD) in patients with suspected infiltrating glioma in the setting of planned surgical interventions
Brief description of study
The goal of this prospective, non-randomized, single-arm study is to evaluate the safety and feasibility of using ExAblate Model 4000 Type-2 Neuro-System as a tool to disrupt the blood brain barrier in a temporary and localized fashion in patients with suspected infiltrating glioma undergoing planned surgical interventions.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
surgery
-
Age: Between 18 Years - 99 Years
-
Gender: All
Updated on
08 Jul 2020.
Study ID: 833809